Radiation Oncology/Therapy: Page 88

Siemens cuts diagnostics jobs, exits linac sector
By AuntMinnieEurope.com staff writers
Siemens Healthcare will eliminate as many as 1,000 jobs in its global diagnostics unit and phase out its participation in the linear accelerator market.
December 21, 2011
Echo helps evaluate cardiotoxicity in cancer patients
By AuntMinnieEurope.com staff writers
Echocardiography is a useful tool to identify and document early warning signs of adverse effects from the chemotherapy drug trastuzumab on the hearts of cancer patients, according to a study presented at Euroecho, held 7-10 December in Budapest.
December 13, 2011
Varian promotes 1st TrueBeam sale in France
By AuntMinnieEurope.com staff writers
Radiation therapy firm Varian Medical Systems announced that the Cancer Research Center of Languedoc-Roussillon at the Centre Val d'Aurelle in Montpelier has used its newly commissioned TrueBeam radiotherapy treatment system on its first patient.
December 11, 2011
External radiation plus high-dose brachytherapy effective for high-risk prostate cancer
By Reuters Health
NEW YORK (Reuters Health) - Ten-year survival rates are high when patients with unfavorable localized prostate cancer are treated with external-beam radiotherapy boosted with conformal high-dose-rate brachytherapy, a Spanish group reports.
November 28, 2011
Reuterslogo
IBA grows sales in Q3
By AuntMinnieEurope.com staff writers
Gains in its proton therapy segment offset a decline in dosimetry products to grow revenues for radiopharmaceutical developer Ion Beam Applications (IBA) in the third quarter.
November 21, 2011
New report underlines continued concern over radiation dose
By Cynthia E. Keen
Inappropriate and/or unnecessary radiation dose exposure from CT scans and radiation therapy is still in the top 10 list of health technology hazards published annually by research and consulting group ECRI Institute.
November 17, 2011
Radiation dose still high on ECRI's technology hazards list
By Cynthia E. Keen
Inappropriate and/or unnecessary radiation dose exposure from CT scans and radiation therapy is still in the top 10 list of health technology hazards published annually by research and consulting group ECRI Institute.
November 17, 2011
Mysterious I-131 release traced to Hungarian firm
By AuntMinnieEurope.com staff writers
The International Atomic Energy Agency announced that the source of iodine-131 (I-131) recently detected in the atmosphere over Europe probably originated from the Institute of Isotopes in Budapest, according to notification from the Hungarian Atomic Energy Authority.
November 16, 2011
Manhattan Isotope inks cyclotron agreement
By AuntMinnieEurope.com staff writers
Manhattan Isotope Technology, with the support of molecular imaging developer Positron, has signed a memorandum of understanding with the ARRONAX cyclotron facility in Nantes, France, that will allow the firms to collaborate on the production of strontium-82 and other medical radionuclides.
November 16, 2011
Vascular Designs gets CE Mark for infusion catheter
By AuntMinnieEurope.com staff writers
Infusion catheter manufacturer Vascular Designs has received CE Mark approval for its IsoFlow infusion catheter.
November 14, 2011
Stereotactic brachytherapy 'highly effective' for certain gliomas in children
By Reuters Health
NEW YORK (Reuters Health) - Stereotactic brachytherapy with iodine-125 seeds is "safe, minimally invasive, and highly effective" in children with inoperable low-grade gliomas, German researchers say.
November 14, 2011
Reuterslogo
IBA awarded Polish supply contract
By AuntMinnieEurope.com staff writers
Radiopharmaceutical developer Ion Beam Applications (IBA) has signed a supply agreement with the Henryk Niewodniczanski Institute of Nuclear Physics of the Polish Academy of Sciences for its proton therapy center in Krakow.
November 9, 2011
Previous Page
Page 88 of 127
Next Page